Xenous (XITO) 10-Q 24 Feb 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Dec. 31, 2019	Feb. 04, 2020
Document And Entity Information
Entity Registrant Name	XENOUS HOLDINGS, INC.
Entity Central Index Key	0001651932
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Dec. 31, 2019
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020
Entity Common Stock Shares Outstanding		760,250,000
EntityFileNumber	000-55512
EntityAddressAddressLine1	Suite 20.03, Plaza 138
EntityAddressAddressLine2	Jalan Ampang
EntityAddressPostalZipCode	50450
EntityTaxIdentificationNumber	870363526
EntityAddressCityOrTown	Kuala Lumpur
LocalPhoneNumber	2181-0150
CityAreaCode	603
EntityAddressStateOrProvince	MALAYSIA

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2019	Mar. 31, 2019
Current Assets
Prepaid expenses		$ 7,000
Total Current Assets		7,000
TOTAL ASSETS		7,000
Current Liabilities
Accounts payable and accrued liabilities	6,274	8,860
Accrued interest, related party	21,177	14,770
Due to related parties	421,717	376,356
Convertible note payable, related party	106,292	106,292
Total Current Liabilities	555,460	506,278
TOTAL LIABILITIES	555,460	506,278
STOCKHOLDERS' DEFICIT
Preferred stock, par value $0.001 per share, 10,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.001 per share, 10,000,000,000 shares authorized, 760,250,000 shares issued and outstanding	760,250	760,250
Capital deficiency	(449,450)	(449,450)
Accumulated deficit	(866,260)	(810,078)
Total Stockholders' Deficit	(555,460)	(499,278)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT		$ 7,000

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2019	Mar. 31, 2019
STOCKHOLDERS' DEFICIT
Preferred stock, shares par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	10,000,000,000	10,000,000,000
Common stock, shares issued	760,250,000	760,250,000
Common stock, shares outstanding	760,250,000	760,250,000

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Statements of Operations (Unaudited)
REVENUES
OPERATING EXPENSES
General and administrative	1,072	3,260	7,361	19,799
Professional fees	13,164	18,755	42,414	151,621
Total Operating Expenses	14,236	22,015	49,775	171,420
OPERATING LOSS	(14,236)	(22,015)	(49,775)	(171,420)
OTHER EXPENSE
Interest expense	(2,144)	(2,144)	(6,407)	(6,407)
Total other expense	(2,144)	(2,144)	(6,407)	(6,407)
NET LOSS	$ (16,380)	$ (24,159)	$ (56,182)	$ (177,827)
Basic and Diluted Loss per Common Share	$ 0	$ 0	$ 0	$ 0
Basic and Diluted Weighted Average Number of Common Shares	760,250,000	760,250,000	760,250,000	760,250,000

Statement Of Stockholder's Equi

Statement Of Stockholder's Equity (Unaudited) - USD ($)	Total	Common Stock [Member]	Capital Deficiency [Member]	Accumulated Deficit [Member]
Balance, shares at Mar. 31, 2018		760,250,000
Balance, amount at Mar. 31, 2018	$ (279,777)	$ 760,250	$ (449,450)	$ (590,577)
Net loss	$ (75,586)			$ (75,586)
Balance, shares at Jun. 30, 2018		760,250,000
Balance, amount at Jun. 30, 2018	$ (355,363)	$ 760,250	$ (449,450)	$ (666,163)
Net loss	$ (78,082)			$ (78,082)
Balance, shares at Sep. 30, 2018		760,250,000
Balance, amount at Sep. 30, 2018	$ (433,445)	$ 760,250	$ (449,450)	$ (744,245)
Net loss	$ (24,159)			$ (24,159)
Balance, shares at Dec. 31, 2018		760,250,000
Balance, amount at Dec. 31, 2018	$ (457,604)	$ 760,250	$ (449,450)	$ (768,404)
Balance, shares at Mar. 31, 2019		760,250,000
Balance, amount at Mar. 31, 2019	$ (499,278)	$ 760,250	$ (449,450)	$ (810,078)
Net loss	$ (17,764)			$ (17,764)
Balance, shares at Jun. 30, 2019		760,250,000
Balance, amount at Jun. 30, 2019	$ (517,042)	$ 760,250	$ (449,450)	$ (827,842)
Net loss	$ (22,038)			$ (22,038)
Balance, shares at Sep. 30, 2019		760,250,000
Balance, amount at Sep. 30, 2019	$ (539,080)	$ 760,250	$ (449,450)	$ (849,880)
Net loss	$ (16,380)			$ (16,380)
Balance, shares at Dec. 31, 2019		760,250,000
Balance, amount at Dec. 31, 2019	$ (555,460)	$ 760,250	$ (449,450)	$ (866,260)

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (56,182)	$ (177,827)
Changes in operating assets and liabilities:
Prepaid expenses	7,000	(4,167)
Accounts payable and accrued liabilities	(2,586)	(38,635)
Accrued interest, related party	6,407	6,406
Net cash used in operating activities	(45,361)	(214,223)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from related party advances	45,361	214,223
Net cash provided by financing activities	45,361	214,223
Net changes in cash and cash equivalents
Cash and cash equivalents - beginning of period
Supplemental Cash Flow Disclosures
Cash paid for interest
Cash paid for income taxes

NATURE OF BUSINESS AND CONTINUA

NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS	9 Months Ended
	Dec. 31, 2019
NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS
NOTE 1 - NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS	M101 Corp. (the Company) was incorporated on May 20, 1980 as Concept Holding Corp. under the laws of the State of Utah. On December 19, 2014, the Company completed a change of domicile merger with Concept Holding Corp., a Nevada corporation which became the surviving entity and Concept Technologies, Inc., a Utah corporation ceased. On July 21, 2017, the Board of Directors of the Company elected to file Articles of Merger with the Nevada SOS whereby it would enter into a statutory merger with its wholly-owned subsidiary, M101 Corp., a Nevada corporation, pursuant to Nevada Revised Statutes 92A.200, et seq. The effect of such merger is the Company is the surviving entity and changed its name to “M101 Corp.” The merger took effect on August 14, 2017. The Company currently has no business operations. On November 2, 2019, a majority of shareholders approved a resolution to change the name of the Company to Xenous Holdings, Inc. (the Company). On November 19, 2019, the Company received notice that the Secretary of State of Nevada accepted the Company’s Certificate of Amendment to its Articles of Incorporation to change the name of the Company to Xenous Holdings, Inc.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Dec. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the nine months ended December 31, 2019 are not necessarily indicative of the results that may be expected for the year ending March 31, 2020. The notes to the unaudited financial statements are condensed, as disclosures that would substantially duplicate the disclosures contained in the audited financial statements for fiscal year 2019 have been omitted. This report should be read in conjunction with the audited financial statements and the footnotes thereto for the fiscal year ended March 31, 2019 included in the Company’s Form 10-K as filed with the Securities and Exchange Commission on July 9, 2019. Use of Estimates The Company prepares its financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Financial Instruments The Company’s financial instruments consist primarily of accounts payable and debts. The carrying amounts of such financial instruments approximate their respective estimated fair value due to the short-term maturities and approximate market interest rates of these instruments. Related Parties We follow ASC 850, ”Related Party Disclosures,” Prepaid Expenses Prepaid expenses relate to prepayment made for future services in advance and will be expensed over time as the benefit of the services is received in the future, expected within one year. Recently Issued Accounting Pronouncements Management has considered all recent accounting pronouncements issued and believes that these recent pronouncements will not have a material effect on the Company’s financial statements. Basic and Diluted Net Loss per Common Share The Company computes basic and diluted earnings (loss) per share amounts in accordance with ASC Topic 260, “ Earnings per Share For the nine months ended December 31, 2019 and December 31, 2018, respectively, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. December 31, December 31, 2019 2018 Shares Shares Convertible Note- July 2017 10,629,200 10,629,200 Diluted loss per share is the same as basic loss per share during periods where net losses are incurred since the inclusion of the potential common stock equivalents would be anti-dilutive as a result of the net loss.

GOING CONCERN

GOING CONCERN	9 Months Ended
	Dec. 31, 2019
GOING CONCERN
NOTE 3 - GOING CONCERN	The Company has not yet generated any revenue since its inception and has an operating loss of $56,182 for the nine months ended December 31, 2019. As of December 31, 2019, the Company has accumulated deficit of $866,260, and negative working capital of $555,460. The Company’s continuation as a going concern is dependent on its ability to execute its operation plan to generate sufficient cash flows from operations to meet its obligations and/or obtaining additional financing from its shareholders or other sources, as may be required. There can be no assurance that the necessary debt or equity financing will be available or will be available on terms acceptable to the Company. We estimate that based on current plans and assumptions, our available cash will not be sufficient to satisfy our cash requirements under our present operating expectations, without further financing, for up to 12 months. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern; however, the above conditions raise substantial doubt about the Company’s ability to do so. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. We are attempting to generate sufficient revenue; however, our cash position may not be sufficient to support our daily operations. While we believe in the viability of our strategy to generate sufficient revenues in the future and in our ability to raise additional funds, there can be no assurances to that effect. The ability of our company to continue as a going concern is dependent upon our ability to further implement our business plan, generate sufficient revenue to cover operating expenses and in our ability to raise additional funds.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Dec. 31, 2019
RELATED PARTY TRANSACTIONS
NOTE 4 - RELATED PARTY TRANSACTIONS	As of December 31, 2019 and March 31, 2019, total amounts due to related parties was $421,717 and $376,356, respectively, as follows: December 31, March 31, 2019 2019 Amount due to director $ 11,590 $ - Amount due to former director 408,877 375,106 Amount due to former shareholder 1,250 1,250 $ 421,717 $ 376,356 During the nine months ended December 31, 2019, the director of the Company, appointed on October 4, 2019, advanced $11,590 to the Company for operating expense payments on behalf of the Company. As of December 31, 2019 and March 31, 2019, the Company owed $11,590 and $0, respectively, to the director of the Company. During the nine months ended December 31, 2019 and 2018, the former director of the Company, who resigned on December 7, 2018, advanced $33,771 and $214,223, respectively, to the Company for operating expense payments on behalf of the Company. As of December 31, 2019 and March 31, 2019, the Company owed $408,877 and $375,106, respectively, to the former director of the Company. As of December 31, 2019 and March 31, 2019, the Company owed $1,250 and $1,250, respectively, to a former shareholder for the payment of transfer agent termination fees on behalf of the Company. The shareholder sold all his shareholdings to the new Director of the Company in December 2018. Convertible Note Convertible notes payable consisted of the following at December 31, 2019 and March 31, 2019: December 31, March 31, 2019 2019 Convertible Note- July 2017 $ 106,292 $ 106,292 On July 5, 2017, the Company issued an 8% convertible note in the principal amount of $106,292 to a former shareholder for the payment of the Company’s promissory notes and accrued interest at $84,588 and accounts payable and accrued liabilities of $21,704. The convertible note is due on demand, bears interest of 8% per annum and is convertible at a conversion price of $0.01 per share. No beneficial conversion was recognized because the note conversion price of $0.01 per share exceeded the Company stock trading price of $0.0001 on July 5, 2017. As of December 31, 2019, and March 31, 2019, the accrued interest payable on the convertible note was $21,177 and $14,770, respectively.

SHARE CAPITAL

SHARE CAPITAL	9 Months Ended
	Dec. 31, 2019
SHARE CAPITAL
NOTE 5 - SHARE CAPITAL	Preferred Stock The Company is authorized to issue an aggregate of 10,000,000 shares of preferred stock with a par value of $0.001 per share. As at December 31, 2019 and March 31, 2019, no preferred shares have been issued. Common Stock The Company is authorized to issue an aggregate of 10,000,000,000 shares of common stock with a par value of $0.001 per share. As of December 31, 2019 and March 31, 2019, the Company had 760,250,000 shares of common stock issued and outstanding.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Dec. 31, 2019
SUBSEQUENT EVENTS
NOTE 6 - SUBSEQUENT EVENTS	Management has evaluated subsequent events through the date these financial statements were issued. Based on our evaluation no material events have occurred that require disclosure.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Dec. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the nine months ended December 31, 2019 are not necessarily indicative of the results that may be expected for the year ending March 31, 2020. The notes to the unaudited financial statements are condensed, as disclosures that would substantially duplicate the disclosures contained in the audited financial statements for fiscal year 2019 have been omitted. This report should be read in conjunction with the audited financial statements and the footnotes thereto for the fiscal year ended March 31, 2019 included in the Company’s Form 10-K as filed with the Securities and Exchange Commission on July 9, 2019.
Use of Estimates	The Company prepares its financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Financial Instruments	The Company’s financial instruments consist primarily of accounts payable and debts. The carrying amounts of such financial instruments approximate their respective estimated fair value due to the short-term maturities and approximate market interest rates of these instruments.
Related Parties	We follow ASC 850, ”Related Party Disclosures,”
Prepaid Expenses	Prepaid expenses relate to prepayment made for future services in advance and will be expensed over time as the benefit of the services is received in the future, expected within one year.
Recently Issued Accounting Pronouncements	Management has considered all recent accounting pronouncements issued and believes that these recent pronouncements will not have a material effect on the Company’s financial statements.
Basic and Diluted Net Loss per Common Share	The Company computes basic and diluted earnings (loss) per share amounts in accordance with ASC Topic 260, “ Earnings per Share For the nine months ended December 31, 2019 and December 31, 2018, respectively, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. December 31, December 31, 2019 2018 Shares Shares Convertible Note- July 2017 10,629,200 10,629,200 Diluted loss per share is the same as basic loss per share during periods where net losses are incurred since the inclusion of the potential common stock equivalents would be anti-dilutive as a result of the net loss.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Dec. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of Exclusion of common stock from diluted share	December 31, December 31, 2019 2018 Shares Shares Convertible Note- July 2017 10,629,200 10,629,200

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	9 Months Ended
	Dec. 31, 2019
RELATED PARTY TRANSACTIONS
Schedule of related party transactions	December 31, March 31, 2019 2019 Amount due to director $ 11,590 $ - Amount due to former director 408,877 375,106 Amount due to former shareholder 1,250 1,250 $ 421,717 $ 376,356
Schedule of convertible note payable, related party	December 31, March 31, 2019 2019 Convertible Note- July 2017 $ 106,292 $ 106,292

NATURE OF BUSINESS AND CONTIN_2

NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS (Detail Narrative)	Nov. 02, 2019	Dec. 31, 2019
NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS
State of incorporation		Utah
Date of incorporation		May 20, 1980
Name change of company description	A majority of shareholders approved a resolution to change the name of the Company to Xenous Holdings, Inc. (the Company)

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - shares	9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Convertible Note- July 2017	10,629,200	10,629,200

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	9 Months Ended
	Dec. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Redemption of convertible shares	Common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive.

GOING CONCERN (Detail Narrative

GOING CONCERN (Detail Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2019
GOING CONCERN
Operating loss	$ (16,380)	$ (24,159)	$ (56,182)	$ (177,827)
Accumulated deficit	(866,260)		(866,260)		$ (810,078)
Working capital deficit	$ (555,460)		$ (555,460)

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)	Dec. 31, 2019	Mar. 31, 2019
Due to related party	$ 421,717	$ 376,356
Former Director [Member]
Due to related party	408,877	375,106
Former Shareholder [Member]
Due to related party	1,250	1,250
Director [Member]
Due to related party	$ 11,590

RELATED PARTY TRANSACTIONS (D_2

RELATED PARTY TRANSACTIONS (Details 1) - USD ($)	Dec. 31, 2019	Mar. 31, 2019
RELATED PARTY TRANSACTIONS
Convertible Note - July 2017	$ 106,292	$ 106,292

RELATED PARTY TRANSACTIONS (D_3

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Jul. 05, 2017	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2019
Due to related party		$ 421,717		$ 376,356
Accrued interest payable		21,177		14,770
Proceeds from related party debt one		45,361	$ 214,223
Convertible Note - July 2017		106,292		106,292
Promissory Notes [Member]
Accrued interest payable	$ 84,588
Convertible Note - July 2017	106,292
Accounts payable and accrued liabilities	$ 21,704
Interest rate	8.00%
Conversion price	$ 0.01
Trading price per share	$ 0.0001
Former Director [Member]
Due to related party		408,877		375,106
Proceeds from related party debt one		33,771	$ 214,223
Former Shareholder [Member]
Due to related party		1,250		1,250
Director [Member]
Due to related party		11,590
Proceeds from related party debt one		$ 11,590

SHARE CAPITAL (Details Narrativ

SHARE CAPITAL (Details Narrative) - $ / shares	Dec. 31, 2019	Mar. 31, 2019
SHARE CAPITAL (Details Narrative)
Preferred stock, par value, per share in dollars	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value in dollars	$ 0.001	$ 0.001
Common stock, shares authorized	10,000,000,000	10,000,000,000
Common stock, shares issued	760,250,000	760,250,000
Common stock, shares outstanding	760,250,000	760,250,000